Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women
References (19)
The climacteric of Chinese factory workers
Maturitas
(1994)- et al.
Dietary flour supplementation decreases postmenopausal hot flushes: Effect of soy and wheat
Maturitas
(1995) - et al.
Psychological well-being, mid-life and the menopause
Maturitas
(1994) - et al.
Physical activity and the menopause experience: A cross-sectional study
Maturitas
(1994) - et al.
The menopausal syndrome
Br J Prev Soc Med
(1974) - et al.
The menopausal hot flush: Facts and fancies
The menopause industry
- et al.
Does physical exercise influence the frequency of postmenopausal hot flushes?
Acta Obstet Gynecol Scand
(1990)
Cited by (146)
Are serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials
2022, MaturitasCitation Excerpt :In a study of perimenopausal women aged 40–59 years living in the UK or Bangladesh, E2 concentration was not associated with experiencing hot flushes in the past 2 weeks [23]. In the Melbourne Women's Midlife Health Project (women aged 48–59) lower serum E2 concentration was associated with higher odds of having any VMS in the past two weeks before adjustment for covariates, but no significant association among either peri- or post-menopausal women after adjustment for covariates [24]. Variations among the studies regarding which covariates were included in statistical models, ages, and menopausal transition stage of participants (peri- vs. post-menopausal), wording of questions regarding symptoms, VMS characterization in statistical models, and E2 and E1 assays may explain why some studies found associations between serum E2 concentration and VMS, and others did not.
Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study
2020, MaturitasCitation Excerpt :Estrogen decline is often accompanied by the development of VMS and women experiencing severe VMS often use MHT to reduce the symptoms. The decline in estrogen is also suggested to be associated with an increased CVD risk [19,20], which might be counteracted by MHT use. However, recent meta-analyses of clinical trials with MHT found no associations for cardiac or stroke mortality [21], or even an increased CHD risk [22].
Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women
2018, Journal of Thrombosis and HaemostasisMidlife Women’s Health
2023, Women’s Healthcare in: Advanced Practice Nursing, Third Edition
This study was supported by grants from the Victorian Health Promotion Foundation, the Public Health Research Development Committee (PHRDC), the National Health and Medical Research Council (NHMRC), the Percy Baxter Trust, the H & L Hecht Trust, the Estate of the late Daniel Scott, ANZ and Perpetual Trustees.